Clinical Significance and Different Expression of Dipeptidyl Peptidase IV and Procalcitonin in Mild and Severe COVID-19

Hamidreza Jamaati; Payam Tabarsi; Naghmeh Bahrami; Fatemeh  Yasari; Mohammad  Varahram; Mehdi Kazempour Dizaji; Seyed Mohammadreza Hashemian; Mahya  Daustany; Maral  Emami; Sadegh Shirian; Ladan  Masumi; Amir  Rasouli; Armita  Narimani; Nasser   Ahmadian; Abdolreza Mohamadnia; Ali Akbar  Velayati

doi:10.22037/jcma.v6i2.34671

Journal of Cellular & Molecular Anesthesia

Current Issue All Issues Accepted Manuscripts Search

Journal Information Editors & Boards Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form New Publisher Announcement Support Contact Us

APC

Authors Guide Submit Manuscript

https://doi.org/10.22037/jcma.v6i2.34671

Clinical Significance and Different Expression of Dipeptidyl Peptidase IV and Procalcitonin in Mild and Severe COVID-19

Author(s):

Hamidreza Jamaati

^,*,

Payam Tabarsi

,

Naghmeh Bahrami

,

Fatemeh Yasari,

Mohammad Varahram,

Mehdi Kazempour Dizaji,

Seyed Mohammadreza Hashemian,

Mahya Daustany ,

Maral Emami ,

Sadegh Shirian

,

Ladan Masumi ,

Amir Rasouli,

Armita Narimani,

Nasser Ahmadian,

Abdolreza Mohamadnia

¹,

Ali Akbar Velayati

1PhD of Molecular Medicine, Virology Research Center, National Research Institute of Tuberculosis & Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran

Journal of Cellular & Molecular Anesthesia:Vol. 6, issue 2; e149671

Published online:May 15, 2021

Article type:Original Articles

How to Cite:Jamaati H, Tabarsi P, Bahrami N, Yasari F, Varahram M, et al. Clinical Significance and Different Expression of Dipeptidyl Peptidase IV and Procalcitonin in Mild and Severe COVID-19. J Cell Mol Anesth. 2021;6(2):e149671. doi: https://doi.org/10.22037/jcma.v6i2.34671

Abstract

Background: Coronavirus has become a global concern in 2019-20. The virus belongs to the coronavirus family, which has been able to infect many patients and victims around the world. The virus originated in the Chinese city of Wuhan, which eventually spread around the world and became a pandemic. Materials and Methods: A total of 60 Patients with severe (n=30) and mild (n=30) symptoms of COIVD-19 were included in this study. Peripheral blood samples were collected from the patients. Real-time PCR was used to compare the relative expression levels of Procalcitonin and dipeptidyl peptidase IV (DPPIV) in a patient with severe and mild Covid-19 infection. Results: Procalcitonin and dipeptidyl peptidase IV markers in the peripheral blood of patients with severe symptoms, were positive in 29 (96.60%) and 26 (86.60%), respectively (n=30); however, positive rates in the mild symptoms patients group were 27 (90%) and 25 (83.30%), respectively. There was a statistically significant difference between these two groups in terms of DDPIV and Procalcitonin (p<0.001). Conclusion: Procalcitonin and DPPIV increase in patients with COVID-19 infection, significantly higher in the patients with more severe clinical symptoms than those with milder ones. More studies will be needed to verify the reliability of the current findings. Keywords: Procalcitonin, DPPIV, Severe symptoms, Mild symptoms, COVID-19

Keywords

Procalcitonin

Dipeptidyl peptidase-4

Severe symptoms

Mild symptoms

COVID-19

References

1.
References are in the PDF file of the article.

Evaluation of Chemokines and Cytokines as Biomarkers for Disease Severity in COVID-19-Infected Patients

Rosa Karimi,

Abdolreza Mohamadnia,

Farzaneh Hosseini,

Naghmeh Bahrami,

Hamidreza Jamaati

Karimi R, Mohamadnia A, Hosseini F, Bahrami N, Jamaati H. Evaluation of Chemokines and Cytokines as Biomarkers for Disease Severity in COVID-19-Infected Patients. Jundishapur J Microbiol. 2024;17(1):e143611. doi: https://doi.org/10.5812/jjm-143611

11

Oct

2023

Evaluation of the Relationship Between Serum miR-200b-3p and miR-214-3p Expression Levels with Soluble ACE2 and TMPRSS2 in COVID-19 Patients

Faezeh Mortazavi,

Mohsen Soltanshahi,

Gholamhossein Tamaddon

Mortazavi F, Soltanshahi M, Tamaddon G. Evaluation of the Relationship Between Serum miR-200b-3p and miR-214-3p Expression Levels with Soluble ACE2 and TMPRSS2 in COVID-19 Patients. Iran J Pharm Res. 2023;22(1):e137832. doi: https://doi.org/10.5812/ijpr-137832

7

Sep

2022

The Different Clinical Characteristics of COVID-19 Patients Between Pediatric and Adults

Awat Karimi,

Shirin Behzadi,

Mehri Rahimi,

Naoshad Mohammadi,

Kaveh Rahimi,

Masomeh Abedini

Karimi A, Behzadi S, Rahimi M, Mohammadi N, Rahimi K, et al. The Different Clinical Characteristics of COVID-19 Patients Between Pediatric and Adults. Zahedan J Res Med Sci. 2022;24(4):e111082. doi: https://doi.org/10.5812/zjrms-111082

12

Oct

2020

Archives of Clinical Infectious Diseases

Analysis of Cardiac Injury Biomarkers in COVID-19 Patients

Salma Abdeladim,

Sara Oualim,

Amal Elouarradi,

Ilham Bensahi,

Rita Aniq Filali,

Mahassine EL Harras

,et al.

Abdeladim S, Oualim S, Elouarradi A, Bensahi I, Aniq Filali R, et al. Analysis of Cardiac Injury Biomarkers in COVID-19 Patients. Arch Clin Infect Dis. 2020;15(4):e105515. doi: https://doi.org/10.5812/archcid.105515

8

Jul

2020

Archives of Pediatric Infectious Diseases

A Review on Coronavirus Disease 2019 (COVID-19) in Pediatric Patients

Solmaz Ohadian Moghadam,

Davoud Afshar

Ohadian Moghadam S, Afshar D. A Review on Coronavirus Disease 2019 (COVID-19) in Pediatric Patients. Arch Pediatr Infect Dis. 2020;8(3):e104225. doi: https://doi.org/10.5812/pedinfect.104225

Import into EndNote Import into BibTex

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 0
Last Update: 3 weeks ago
Scopus by Title: 0
Last Update: 3 weeks ago
Scopus by Title (Ref): 0
Last Update: 3 weeks ago
CrossRef: 0
Last Update: 1 day ago

Metrics

Licensing and reuse information

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC

Search Relations

Author(s):

Hamidreza Jamaati:[PubMed][Scholar]
Payam Tabarsi:[PubMed][Scholar]
Naghmeh Bahrami:[PubMed][Scholar]
Fatemeh Yasari:[PubMed][Scholar]
Mohammad Varahram:[PubMed][Scholar]
Mehdi Kazempour Dizaji:[PubMed][Scholar]
Seyed Mohammadreza Hashemian:[PubMed][Scholar]
Mahya Daustany :[PubMed][Scholar]
Maral Emami :[PubMed][Scholar]
Sadegh Shirian:[PubMed][Scholar]
Ladan Masumi :[PubMed][Scholar]
Amir Rasouli:[PubMed][Scholar]
Armita Narimani:[PubMed][Scholar]
Nasser Ahmadian:[PubMed][Scholar]
Abdolreza Mohamadnia:[PubMed][Scholar]
Ali Akbar Velayati:[PubMed][Scholar]

Outlines

Clinical Significance and Different Expression of Dipeptidyl Peptidase IV and Procalcitonin in Mild and Severe COVID-19

Abstract

References

Similar Articles

Evaluation of Chemokines and Cytokines as Biomarkers for Disease Severity in COVID-19-Infected Patients

Evaluation of the Relationship Between Serum miR-200b-3p and miR-214-3p Expression Levels with Soluble ACE2 and TMPRSS2 in COVID-19 Patients

The Different Clinical Characteristics of COVID-19 Patients Between Pediatric and Adults

Analysis of Cardiac Injury Biomarkers in COVID-19 Patients

A Review on Coronavirus Disease 2019 (COVID-19) in Pediatric Patients

Crossmark

Checking

Last Update: 3 weeks ago

Last Update: 3 weeks ago

Last Update: 3 weeks ago

Last Update: 1 day ago